Skip to content

To investigate the mechanism of thyroid hormone on cognitive function

Study for the mechanism of thyroid hormone on cognitive function

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900022208
Enrollment
Unknown
Registered
2019-03-30
Start date
2019-04-01
Completion date
Unknown
Last updated
2019-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

thyroid dysfunction

Interventions

hyperthyroidism:131I therapy
acute hypothyroidism:levothyroxine replacement

Sponsors

Union Hospital of Fujian Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed with hyperthyroidism and agreed to receive iodine-131 treatment; 2. Agree to participate in the study and sign the informed consent; 3. Willing to abide by relevant experimental program regulations and come to review and conduct relevant inspections regularly as required.

Exclusion criteria

Exclusion criteria: 1. Cognitive dysfunction secondary to various causes (including vascular, inflammatory, degenerative, traumatic, etc.); 2. Patients with severe cardiovascular and cerebrovascular diseases or severe mental diseases; 3. Poor compliance; 4. Other serious physical diseases or severe abnormalities of liver and kidney function in the laboratory, affecting the interviewees; 5. There are objective factors that cannot complete the interview (economic factors, traffic factors, etc.)

Design outcomes

Primary

MeasureTime frame
Cannabinoid receptor;interleukin;neurofilament light;

Countries

China

Contacts

Public ContactLIN Lizhen

Union Hospital of Fujian Medical University

445894931@qq.com+86 13850104548

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026